Patent: 7,429,387
✉ Email this page to a colleague
Summary for Patent: 7,429,387
Title: | Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction |
Abstract: | The present invention related to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin. |
Inventor(s): | Schmidt; Richard A. (Arvada, CO) |
Assignee: | The Regents of the University of Colorado (Boulder, CO) |
Application Number: | 11/077,895 |
Patent Claims: | see list of patent claims |
Details for Patent 7,429,387
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Abbvie Inc. | BOTOX COSMETIC | onabotulinumtoxina | For Injection | 103000 | December 09, 1991 | ⤷ Sign Up | 2017-07-15 |
Abbvie Inc. | BOTOX | onabotulinumtoxina | For Injection | 103000 | December 09, 1991 | ⤷ Sign Up | 2017-07-15 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 7,429,387
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | E314085 | ⤷ Sign Up |
Austria | E320815 | ⤷ Sign Up |
Austria | E339220 | ⤷ Sign Up |
Austria | E448792 | ⤷ Sign Up |
Austria | E552006 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |